Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL607736 | 1.00 | — | — | |
| Oxalic Acid SCHEMBL18422239 | 0.94 | — | — | |
| Oxalic Acid SCHEMBL1128067 | 0.94 | — | — | |
| Oxalic Acid SCHEMBL29067655 | 0.94 | CA1 (0.50) | — | |
| Oxalic Acid SCHEMBL50018 | 0.94 | — | — | |
| Oxalic Acid SCHEMBL7263453 | 0.94 | CA1 (0.50) | — | |
| Oxalic Acid SCHEMBL29236278 | 0.94 | — | — | |
| Oxalic Acid SCHEMBL28412035 | 0.94 | CA1 (0.50) | — | |
| Oxalic Acid SCHEMBL20553204 | 0.94 | — | — | |
| Oxalic Acid SCHEMBL27509480 | 0.94 | CA1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3209323-B1 | IMPROVED CLOTTING COMPOSITION | Q SERA PTY LTD (AU) | 2024-06-12 | — | — | EP | disclosed |
| US-11666078-B2 | Dairy-based sugar substitute | SWEETSCIENCE, LLC (US) | 2023-06-06 | — | — | US | disclosed |
| EP-4147041-A1 | LIQUID CHROMATOGRAPHY BASED DETECTION AND QUANTITATION OF PHOSPHO PRODRUGS AND THEIR ACTIVE METABOLITES | Waters Technologies Corporation (US) | 2023-03-15 | — | — | EP | disclosed |
| US-11590095-B2 | Fumarate ester dosage forms | BANNER LIFE SCIENCES LLC (US) | 2023-02-28 | — | — | US | disclosed |
| CN-115552239-A | Liquid chromatography-based detection and quantification of phosphate prodrugs and active metabolites thereof | 沃特世科技公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-114703167-A | Improved blood clotting compositions | Q-塞拉有限公司 | 2022-07-05 | — | — | CN | disclosed |
| EP-4010707-A1 | METHODS FOR DETECTING ASSAY INTERFERENTS AND INCREASING DYNAMIC RANGE | Abbott Laboratories (US) | 2022-06-15 | — | — | EP | disclosed |
| CN-107106662-B | Improved blood coagulation compositions | Q-塞拉有限公司 | 2022-03-25 | — | — | CN | disclosed |
| CN-114126615-A | Opioid receptor antagonist prodrugs | 尼萨姆实验室公司 | 2022-03-01 | — | — | CN | disclosed |
| US-11215628-B2 | Methods of automatized sample loading and processing and devices and systems related thereto | ABBOTT MOLECULAR INC. (US) | 2022-01-04 | — | — | US | disclosed |
| US-20060154322-A1 | Methods and systems for determining and controlling glycemic responses | ATKINS NUTRITIONALS, INC. | 2006-07-13 | — | — | US | disclosed |
| EP-1613179-A4 | METHODS AND SYSTEMS FOR DETERMINING AND CONTROLLING GLYCEMIC RESPONSES | ATKINS NUTRITIONALS INC (US) | 2006-05-17 | — | — | EP | disclosed |
| EP-1613179-A2 | METHODS AND SYSTEMS FOR DETERMINING AND CONTROLLING GLYCEMIC RESPONSES | Atkins Nutritionals, Inc. (US) | 2006-01-11 | — | — | EP | disclosed |
| WO-2005040752-A2 | METHODS AND SYSTEMS FOR DETERMINING AND CONTROLLING GLYCEMIC RESPONSES | ATKINS NUTRITIONALS, INC. (US) | 2005-05-06 | — | — | WO | disclosed |
| EP-1395681-A1 | PHARMACOLOGICAL APPLICATIONS OF MITOCHONDRIAL DNA ASSAYS | The University of British Columbia (CA) | 2004-03-10 | — | — | EP | disclosed |
| US-20040043106-A1 | Methods and systems for determining and controlling glycemic responses | ATKINS NUTRITIONALS, INC. | 2004-03-04 | — | — | US | disclosed |
| US-20030099933-A1 | Pharmacological applications of mitochondrial DNA assays | UNIVERSITY OF BRITISH COLUMBIA, THE (CA) | 2003-05-29 | — | — | US | disclosed |
| WO-2002097124-A1 | PHARMACOLOGICAL APPLICATIONS OF MITOCHONDRIAL DNA ASSAYS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2002-12-05 | — | — | WO | disclosed |
| CN-1374082-A | Use of glycogen sulphofoenzyme inhibitor | PFIZER (US) | 2002-10-16 | — | — | CN | disclosed |
| US-5028437-A | Administering aqueous solution of glucose, sodium chloride, other salts; for restoring electrolyte balance, hydration | THE STATE OF VICTORIA (AU) | 1991-07-02 | — | — | US | disclosed |